Giant panda ribosomal subunit gene RPL23a recombinant protein and application thereof in preparing anti-cancer drugs

A ribosomal protein and recombinant protein technology, which is applied in the direction of anti-tumor drugs, drug combinations, peptide/protein components, etc., can solve the problem that there is no report on the anti-cancer function of the recombinant protein of the giant panda ribosomal protein subunit gene RPL23a

Inactive Publication Date: 2012-07-11
CHINA WEST NORMAL UNIVERSITY
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the research of rpl23a gene in humans and some animals and plants has been reported, and the cloning and analysis of genes such as ribosomal protein subunits S7, S12, S15, S20, S24, S28 and LSM3 of giant pandas have also been reported (Luo Xiaoyan et al., 2008 ; Du Yujie et al., 2009; Hao Yanze et al., 2009; Hou Yiling et al., 2009; Zhang Tian et al., 2009; Hou W R et al., 2009; Zhang et al., 2009), while the rpl23a gene and its RPL23a protein of giant pandas are well known at home and abroad Not yet reported
In particular, there is no report on the anti-cancer function of the recombinant protein of the giant panda ribosomal protein subunit gene RPL23a at home and abroad.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Giant panda ribosomal subunit gene RPL23a recombinant protein and application thereof in preparing anti-cancer drugs
  • Giant panda ribosomal subunit gene RPL23a recombinant protein and application thereof in preparing anti-cancer drugs
  • Giant panda ribosomal subunit gene RPL23a recombinant protein and application thereof in preparing anti-cancer drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0007] The present invention will be described in detail below in conjunction with specific embodiments.

[0008] 1.1 Materials and methods

[0009] 1.1.1 Materials and reagents

[0010] Giant panda skeletal muscle tissue was obtained from a dead giant panda at the China Conservation and Research Center for the Giant Panda in Wolong, Sichuan. To prevent RNA degradation, the tissue was immediately frozen and stored in liquid nitrogen; human laryngeal carcinoma Hep-2 cells (purchased from Biochemical Biochemical and Institute of Molecular Immunology). Total RNA Extraction Kit Total Tissue / cell RNA Extractiob Kits was purchased from Waton Company; Reverse Transcription System was purchased from Promega Company; Gel Recovery Kit was purchased from OMEGA Company; T Vector Kit (PMD-18T Vector Systems) And restriction endonucleases Sma I, Pst I, SeaII, EcoR I and Sal I were purchased from Treasure Bio (Dalian) Co., Ltd.; Taqplus polymerase was purchased from Shanghai Bioengineering...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention discloses a giant panda ribosomal subunit gene RPL23a recombinant protein and application thereof in preparing anti-cancer drugs. The amino acid sequence of the recombinant protein is defined by SEQ ID NO: 7. The inhibitory effect of giant panda ribosomal subunit gene RPL23a recombinant protein on growth of Hep-2 cells is observed by acting the giant panda ribosomal subunit gene RPL23a recombinant protein on the Hep-2 cells, which reveals the anticancer function of the giant panda ribosomal subunit gene RPL23a recombinant protein and provides scientific basis and resources for developing anti-cancer protein drugs and studying on anti-cancer mechanism.

Description

technical field [0001] The invention relates to a giant panda ribosomal protein subunit gene RPL23a recombinant protein and its application in the preparation of anticancer drugs, belonging to the field of biotechnology. Background technique [0002] Mammalian ribosomes are composed of 4 RNAs and about 80 different proteins. The names of ribosomal proteins are related to the size of the protein in the ribosome. The small subunit ribosomal proteins are named S1 to S31, and the large subunit The base ribosomal proteins are named L1 to LA4. The RPL23a protein is a component of the 60S ribosomal protein, encoded by the rpl23a gene. At present, the research of rpl23a gene in humans and some animals and plants has been reported, and the cloning and analysis of genes such as ribosomal protein subunits S7, S12, S15, S20, S24, S28 and LSM3 of giant pandas have also been reported (Luo Xiaoyan et al., 2008 ; Du Yujie et al., 2009; Hao Yanze et al., 2009; Hou Yiling et al., 2009; Zhan...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/47A61K38/17A61P35/00
Inventor 侯万儒侯怡铃伍春莲苏秀兰孙冰李俊丁祥王婷
Owner CHINA WEST NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products